virginia catalyst
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy
901 E. Cary Street
Suite 900
Richmond, Virginia

(804) 545-5799

Virginia Catalyst Announces COVID-19 Grant Funding

1/28/2021

0 Comments

 
RICHMOND, VA – January 28, 2021  – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is conducting a formalized, competitive, one-time COVID-19 Therapeutic Drug Grant Funding Round of up to $5,000,000 to:
  • Support the acceleration of clinical testing by one or more Virginia companies of a therapeutic drug that treats life-threatening symptoms caused by COVID-19
  • Encourage collaborative partnerships between investigators at one or more Virginia research universities and each grant recipient
  • Increase Virginia’s national and global competitiveness in the life sciences by creating critical mass through collaborations between and among Virginia’s research universities and industry partners
  • Create investment or jobs in Virginia
The Catalyst is now accepting applications for this special COVID-19 Grant Round.

Learn more about the: Funding Criteria for COVID-19 Grant Round

Read the full press release
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

      Subscribe to our Newsletter

    Subscribe

    Archives

    May 2023
    April 2023
    December 2021
    October 2021
    March 2021
    January 2021
    October 2020
    April 2020
    June 2019
    April 2019
    January 2019
    August 2018
    July 2018
    May 2018
    February 2018
    December 2017
    September 2017
    July 2017
    June 2017
    April 2017
    September 2015
    August 2015
    April 2015

    Categories

    All

    RSS Feed

Home
Terms & Conditions
​Privacy
Picture
Contact Us
Mike Grisham, CEO
(804) 543-5200
[email protected]
  • Home
  • Grant Funding
    • Apply for Funding
    • History of Awards
    • Downloads
  • News
  • About
    • Our Team
    • Contact Us
    • Terms & Conditions
    • Privacy